Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Rheumatoid Arthritis Initiating as Palindromic Rheumatism: A Distinct Clinical Phenotype?

Castellanos-Moreira R, Rodriguez-Garcia SC, Gómez-Puerta JA, Ruiz-Esquide V, Camacho O, Ramírez J, Cuervo A, Morlá R, Cañete JD, Haro I, Sanmarti R.

J Rheumatol. 2019 Aug 1. pii: jrheum.190061. doi: 10.3899/jrheum.190061. [Epub ahead of print]

PMID:
31371648
2.

Exposure-response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components.

Bastida C, Soy D, Ruiz-Esquide V, Sanmartí R, Huitema ADR.

Br J Clin Pharmacol. 2019 Aug;85(8):1710-1718. doi: 10.1111/bcp.13954. Epub 2019 Jun 17.

PMID:
30958574
3.

Ultrasound findings in palindromic rheumatism.

Sanmarti R, Ramírez J, Castellanos-Moreira R, Cabrera-Villalba SR, Ruiz-Esquide V, Salvador G.

Ann Rheum Dis. 2018 Dec 14. pii: annrheumdis-2018-214832. doi: 10.1136/annrheumdis-2018-214832. [Epub ahead of print] No abstract available.

PMID:
30552178
4.

Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study.

Inciarte-Mundo J, Ramirez J, Hernández MV, Ruiz-Esquide V, Cuervo A, Cabrera-Villalba SR, Pascal M, Yagüe J, Cañete JD, Sanmarti R.

Arthritis Res Ther. 2018 Dec 13;20(1):275. doi: 10.1186/s13075-018-1764-z.

5.

Tocilizumab in the treatment of adult rheumatoid arthritis.

Sanmartí R, Ruiz-Esquide V, Bastida C, Soy D.

Immunotherapy. 2018 Mar 1;10(6):447-464. doi: 10.2217/imt-2017-0173. Epub 2018 Mar 2. Review.

PMID:
29495891
6.

Fixed dosing of intravenous tocilizumab in rheumatoid arthritis. Results from a population pharmacokinetic analysis.

Bastida C, Ruiz-Esquide V, Pascal M, de Vries Schultink AHM, Yagüe J, Sanmartí R, Huitema ADR, Soy D.

Br J Clin Pharmacol. 2018 Apr;84(4):716-725. doi: 10.1111/bcp.13500. Epub 2018 Feb 7.

7.

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study.

Balsa A, Lojo-Oliveira L, Alperi-López M, García-Manrique M, Ordóñez-Cañizares C, Pérez L, Ruiz-Esquide V, Corrales A, Narváez J, Rey-Rey J, Rodríguez-Lozano C, Ojeda S, Muñoz-Fernández S, Nolla JM, García-Torrón J, Gamero F, García-Vicuña R, Hernández-Cruz B, Campos J, Rosas J, García-Llorente JF, Gómez-Centeno A, Cáliz R, Sanmartí R, Bermúdez A, Abasolo-Alcázar L, Fernández-Nebro A, Rodríguez-Rodríguez L, Marras C, González-Gay MÁ, Hmamouchi I, Martín-Mola E.

Reumatol Clin. 2019 Mar - Apr;15(2):102-108. doi: 10.1016/j.reuma.2017.06.002. Epub 2017 Jul 12. English, Spanish.

8.

Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis.

Cabrera-Villalba S, Gomara MJ, Cañete JD, Ramírez J, Salvador G, Ruiz-Esquide V, Hernández MV, Inciarte-Mundo J, Haro I, Sanmartí R.

Arthritis Res Ther. 2017 Jun 15;19(1):141. doi: 10.1186/s13075-017-1329-6.

9.

Clinical and sonographic biomarkers of structural damage progression in RA patients in clinical remission: A prospective study with 12 months follow-up.

Ramírez J, Narváez JA, Ruiz-Esquide V, Hernández-Gañán J, Cuervo A, Inciarte-Mundo J, Hernández MV, Sampayo-Cordero M, Pablos JL, Sanmartí R, Cañete JD.

Semin Arthritis Rheum. 2017 Dec;47(3):303-309. doi: 10.1016/j.semarthrit.2017.04.007. Epub 2017 May 1.

PMID:
28549731
10.

Vasculitic neuropathy induced by pembrolizumab.

Aya F, Ruiz-Esquide V, Viladot M, Font C, Prieto-González S, Prat A, Arance A.

Ann Oncol. 2017 Feb 1;28(2):433-434. doi: 10.1093/annonc/mdw613. No abstract available.

PMID:
27864214
11.

Life-threatening colitis and complete response with ipilimumab in a patient with metastatic BRAF-mutant melanoma and rheumatoid arthritis.

Aya F, Gaba L, Victoria I, Fernandez-Martinez A, Ruiz-Esquide V, Pineda E, Tosca M, Viladot M, Pereira V, Malvehy J, Prat A, Arance A.

ESMO Open. 2016 Feb 8;1(1):e000032. eCollection 2016.

12.

Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.

Ramírez J, Inciarte-Mundo J, Cuervo A, Ruiz-Esquide V, Hernández MV, Sanmartí R, Cañete JD.

Clin Exp Rheumatol. 2017 Jan-Feb;35(1):74-79. Epub 2016 Oct 7.

PMID:
27749227
13.

Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.

Inciarte-Mundo J, Ramirez J, Hernández MV, Ruiz-Esquide V, Cuervo A, Cabrera-Villalba SR, Pascal M, Yagüe J, Cañete JD, Sanmarti R.

Arthritis Res Ther. 2016 Jul 8;18(1):160. doi: 10.1186/s13075-016-1032-z.

14.

Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission.

Ramírez J, Celis R, Usategui A, Ruiz-Esquide V, Faré R, Cuervo A, Sanmartí R, Pablos JL, Cañete JD.

Arthritis Res Ther. 2016 Mar 31;18:74. doi: 10.1186/s13075-016-0970-9.

15.

Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.

Inciarte-Mundo J, Victoria Hernández M, Ruiz-Esquide V, Raquel Cabrera-Villalba S, Ramirez J, Cuervo A, Pascal M, Yagüe J, Cañete JD, Sanmarti R.

Arthritis Care Res (Hoboken). 2016 Jul;68(7):899-906. doi: 10.1002/acr.22795. Erratum in: Arthritis Care Res (Hoboken). 2017 Jan;69(1):155.

16.

Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants.

Inciarte-Mundo J, Ruiz-Esquide V, Hernández MV, Cañete JD, Cabrera-Villalba SR, Ramirez J, Yagüe J, Sanmarti R.

Rheumatology (Oxford). 2015 Dec;54(12):2239-43. doi: 10.1093/rheumatology/kev251. Epub 2015 Aug 4.

PMID:
26242859
17.

Inflammatory arthropathy of the manubriosternal joint.

Ruiz-Esquide V, García AI, Ramírez J, Guañabens N.

Rheumatology (Oxford). 2014 Oct;53(10):1731. doi: 10.1093/rheumatology/keu261. Epub 2014 Jul 26. No abstract available.

PMID:
25065004
18.

Is there subclinical synovitis in patients with palindromic rheumatism in the intercritical period? a clinical and ultrasonographic study according to anticitrullinated protein antibody status.

Cabrera-Villalba S, Ramirez J, Salvador G, Ruiz-Esquide V, Hernández MV, Inciarte-Mundo J, Gómez-Puerta JA, Cañete JD, Sanmarti R.

J Rheumatol. 2014 Aug;41(8):1650-5. doi: 10.3899/jrheum.131545. Epub 2014 Jul 15.

PMID:
25028368
19.

Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and -negative rheumatoid arthritis patients.

Gómez-Puerta JA, Celis R, Hernández MV, Ruiz-Esquide V, Ramírez J, Haro I, Cañete JD, Sanmartí R.

Arthritis Res Ther. 2013 Nov 7;15(6):R182. doi: 10.1186/ar4372.

20.

Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers.

Ramírez J, Ruíz-Esquide V, Pomés I, Celis R, Cuervo A, Hernández MV, Pomés J, Pablos JL, Sanmartí R, Cañete JD.

Arthritis Res Ther. 2014 Jan 8;16(1):R5. doi: 10.1186/ar4431.

21.

Reduction of biological agent dose in rheumatic diseases: descriptive analysis of 153 patients in clinical practice conditions.

Inciarte-Mundo J, Hernández MV, Rosario V, Ruiz-Esquide V, Cabrera-Villalba S, Ramírez J, Cañete JD, Sanmartí R.

Reumatol Clin. 2014 Jan-Feb;10(1):10-6. doi: 10.1016/j.reuma.2013.04.012. Epub 2013 Jul 19. English, Spanish.

22.

Laryngeal assessment by videolaryngostroboscopy in patients with rheumatoid arthritis.

Gómez-Puerta JA, Cisternas A, Hernández MV, Ruiz-Esquide V, Vilaseca I, Sanmartí R.

Reumatol Clin. 2014 Jan-Feb;10(1):32-6. doi: 10.1016/j.reuma.2013.04.006. Epub 2013 Jul 3. English, Spanish.

23.

Rheumatoid arthritis: a clinical overview of new diagnostic and treatment approaches.

Sanmartí R, Ruiz-Esquide V, Hernández MV.

Curr Top Med Chem. 2013;13(6):698-704. Review.

PMID:
23574518
24.

Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study.

Sanmartí R, Cabrera-Villalba S, Gómez-Puerta JA, Ruiz-Esquide V, Hernández MV, Salvador G, Ramirez J, Viñas O, Cañete JD.

J Rheumatol. 2012 Oct;39(10):1929-33. doi: 10.3899/jrheum.120568. Epub 2012 Aug 1.

PMID:
22859345
25.

Tobacco and other environmental risk factors in rheumatoid arthritis.

Ruiz-Esquide V, Sanmartí R.

Reumatol Clin. 2012 Nov-Dec;8(6):342-50. doi: 10.1016/j.reuma.2012.02.011. Epub 2012 May 17. Review. English, Spanish.

26.

Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease?

Ruiz-Esquide V, Gómara MJ, Peinado VI, Gómez Puerta JA, Barberá JA, Cañete Jde D, Haro I, Sanmartí R.

Clin Rheumatol. 2012 Jul;31(7):1047-50. doi: 10.1007/s10067-012-1971-y. Epub 2012 Mar 31.

PMID:
22466712
27.

Effects of smoking on disease activity and radiographic progression in early rheumatoid arthritis.

Ruiz-Esquide V, Gómez-Puerta JA, Cañete JD, Graell E, Vazquez I, Ercilla MG, Viñas O, Gómez-Centeno A, Haro I, Sanmartí R.

J Rheumatol. 2011 Dec;38(12):2536-9. doi: 10.3899/jrheum.110410. Epub 2011 Nov 1.

PMID:
22045838
28.

Relapsing polychondritis: a new adverse event secondary to the use of tumour necrosis factor antagonists?

Hernández MV, Ruiz-Esquide V, Gómez-Caballero ME, Gómez-Puerta JA, Cañete JD, Sanmartí R.

Rheumatology (Oxford). 2011 Aug;50(8):1523-5. doi: 10.1093/rheumatology/ker144. Epub 2011 May 18. No abstract available.

PMID:
21593064
29.

Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review.

Gifre L, Ruiz-Esquide V, Xaubet A, Gómez-Puerta JA, Hernández MV, Sanmartí R.

Arch Bronconeumol. 2011 Apr;47(4):208-12. doi: 10.1016/j.arbres.2010.05.011. Epub 2010 Jul 17.

30.

[Abnormalities of bone metabolism in bariatric surgery].

Ruiz-Esquide V, Peris P, Gifre L, Guañabens N.

Med Clin (Barc). 2011 Feb 26;136(5):215-21. doi: 10.1016/j.medcli.2009.12.020. Epub 2010 Apr 24. Review. Spanish.

PMID:
20417940
31.

Development of alopecia areata after biological therapy with TNF-alpha Blockers: description of a case and review of the literature.

Hernández MV, Nogués S, Ruiz-Esquide V, Alsina M, Cañete JD, Sanmartí R.

Clin Exp Rheumatol. 2009 Sep-Oct;27(5):892-3. Review. No abstract available.

PMID:
19917182
32.

Idiopathic osteoporosis in premenopausal women. Clinical characteristics and bone remodelling abnormalities.

Peris P, Ruiz-Esquide V, Monegal A, Alvarez L, Martínez de Osaba MJ, Martínez-Ferrer A, Reyes R, Guañabens N.

Clin Exp Rheumatol. 2008 Nov-Dec;26(6):986-91.

PMID:
19210860

Supplemental Content

Loading ...
Support Center